ATRA

Atara Biotherape

• TipRanks·5d ago

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• NASDAQ·6d ago

  Atara Resubmits Tabelecleucel BLA To FDA

• TipRanks·6d ago

  Atara reports resubmission of tabelecleucel BLA to FDA

• Benzinga·6d ago

  Atara Biotherapeutics' Pierre Fabre Pharmaceuticals Partner Refiles Tabelecleucel Biologics License Application With FDA

• Seeking Alpha·09/15 10:30

  HQL: The Rally That Makes Growth Harder (Rating Downgrade)

• Benzinga·09/08 12:05

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• NASDAQ·09/08 04:11

  ISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision

• Simply Wall St·09/06 14:36

  Independent Director of Atara Biotherapeutics Picks Up 272% More Stock

• TipRanks·08/31 14:35

  Mizuho Securities Remains a Buy on Atara Biotherapeutics (ATRA)

• TipRanks·08/27 02:08

  Top Exec’s Stock Move Sends New Signal at Atara Biotherapeutics

• TipRanks·08/14 06:01

  Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic Progress

• Benzinga·08/12 20:25

  Atara Biotherapeutics Q2 EPS $(0.32), Inline, Sales $630.000K Beat $366.667K Estimate

• Seeking Alpha·08/12 20:16

  Atara Biotherapeutics GAAP EPS of -$0.32 misses by $0.06, revenue of $0.63M beats by $0.26M

• Dow Jones·08/12 20:05

  Press Release: Atara Biotherapeutics Announces -2-

• Dow Jones·08/12 20:05

  Press Release: Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress